Synergy Biomedical Launches BIOSPHERE® MIS II, a Next Generation Minimally Invasive Bone Graft Delivery System | Business

WAYNE, Pa.–(BUSINESS WIRE)–March 1, 2022–

Synergy Biomedical, LLC, a developer of innovative biomaterials products, today announced the launch of BIOSPHERE ® MIS II, the next generation minimally invasive bone graft delivery system. Synergy continues to add solutions for surgeons with new innovative biomaterials products to an already successful portfolio. Building on the proven success of the first generation design, BIOSPHERE® MIS II utilizes a preloaded bone graft cannula and streamlined trigger-based system as a bone graft delivery solution optimized for the unique challenges of mini surgery. -invasive.

The BIOSPHERE ® MIS II System enables strategic and controlled placement of Synergy’s next-generation synthetic bone graft product (BIOSPHERE ® PUTTY) in minimally invasive open, minimally open, and percutaneous environments. Continuing the proven success of the original BIOSPHERE ® MIS System, the BIOSPHERE ® MIS II Bone Graft Delivery System again consists of several innovative new features. A new portable dispenser, improved trigger configuration and graft delivery cannula, preloaded with BIOSPHERE ® PUTTY.

“BIOSPHERE ® MIS II is a low-profile graft delivery system that allows me to place the graft in hard-to-reach places without obstructing my view. My favorite feature is being able to control the amount of graft that is delivered by simply deploying the trigger handle,” said Dr. Barcohana, MD (spinal surgeon at Southern California Orthopedic Institute in alliance with UCLA Health). “MIS II is a next-generation system that provides me with the solutions I need to meet the unique challenges of minimally invasive spine surgery.”

BIOSPHERE ® MIS II design advances include new locking technology that provides audible and tactile confirmation for a secure locked connection between cannula and dispenser. A low-profile system maximizes surgeons’ view when placing the graft around implanted material and hard-to-reach anatomical locations. An improved trigger design gives surgeons full control of BIOSPHERE ® PUTTY delivery location and volume. The BIOSPHERE ® MIS II System is a uniquely designed two-piece assembly specifically designed to increase efficiency in the operating room.

BIOSPHERE ® MIS II PUTTY uses patented bioactive glass spheres that have been shown in vivo to lead to faster and stronger bone formation. The product provides surgeons with a moldable bone graft material that has one of the highest bioactive glass contents on the market.

About Synergy Biomedical, LLC

Founded in 2011, Synergy Biomedical is a privately held medical device company focused on bringing innovative and positively disruptive biomaterial-based products to the orthopedic and spine markets. The company’s BIOSPHERE ® technology represents a unique approach to advancing bone grafting technology and improving bone healing and patient outcomes.

See the source version on

CONTACT: Kevin Booth

[email protected]




SOURCE: Synergy Biomedical, LLC

Copyright BusinessWire 2022.

PUBLISHED: 03/01/2022 15:12 / DISK: 03/01/2022 15:12

Copyright BusinessWire 2022.

About Lucille Thompson

Check Also

This fragrant rose garden in France is now at the heart of the world of Dior skincare

Head to Granville in northern France and you’ll find Dior’s latest launch: the Dior Rose …